A pharmaceutical composition for treating sequelae of cardiac bypass and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of heart bypass and composition, which is applied in the field of pharmaceutical composition and its preparation, and can solve problems such as no treatment, no cure, and no curative effect
Active Publication Date: 2017-11-07
BOZHOU YONGGANG PIECES FACTORY
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Western medicine has no suitable treatment method and cannot cure
The medicine of the motherland is extensive and profound. Through the combination of prescriptions, the research on the treatment of myocardial ischemia after heart bypass surgery has just begun, and there is no drug with confirmed efficacy.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0027] Safflower, yam, Poria cocos, wood beetle, earthworm, and leech are crushed into fine powder and sieved. The remaining ten flavors were decocted twice, 30 minutes each time, concentrated, precipitated with 50% alcohol, filtered, and the filtrate was concentrated and spray-dried. Mix well, make granules, dry, and make 1000 pieces, that is to say.
[0032] After decocting the above fifteen flavors, concentrate, precipitate with 50% alcohol, filter, concentrate the filtrate, decoct safflower separately, mix the two, filter, and make 1000ml of oral liquid.
Embodiment 3
[0034] 1. Prescription:
[0035] 110g of safflower, 80g of astragalus, 80g of angelica, 70g of Rehmannia glutinosa, 70g of Yizhiren, 70g of sand garden seed, 60g of dodder seed, 100g of yam, 80g of poria cocos, 60g of hawthorn, 90g of sealwort, 60g of mulberry, 40g of earthworm, 50g of earthworm, 60g of leech , licorice 60g.
[0036] 2. Process:
[0037] Safflower, yam, Poria cocos, wood beetle, earthworm, and leech are crushed into fine powder and sieved. The remaining ten flavors are decocted in water, concentrated, precipitated with 50% alcohol, filtered, concentrated the filtrate, mixed with the combined medicine powder, made into water pills, and made into 1000 capsules, to get ready.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention aims at disclosing a pharmaceutical composition for treating the sequelae of heart pass and a preparation method thereof. The pharmaceutical composition disclosed by the invention is prepared from the following active pharmaceutical ingredients in parts by weight: 120-220 parts of safflower, 80-180 parts of radix astragali, 80-120 parts of radix angelicae sinensis, 80-150 parts of radix rehmanniae preparata, 50-100 parts of fructus alpiniae oxyphyllae, 50-100 parts of flatstem milkvetch seed, 30-100 parts of semen cuscutae, 30-160 parts of rhizoma dioscoreae, 30-120 parts of poria cocos, 30-120 parts of fructus crataegi, 30-100 parts of rhizoma polygonati, 20-120 parts of mulberry, 30-90 parts of ground beeltle, 10-80 parts of earthworm, 10-80 parts of leech and 30-150 parts of radix glycyrrhizae. The medicine disclosed by the invention can be added with conventional accessories and prepared into clinically acceptable tablets, granules, pills, capsules, oral liquid and the like according to a conventional process.
Description
technical field [0001] The invention relates to a pharmaceutical composition and a preparation method thereof, in particular to a pharmaceutical composition for treating sequelae of cardiac bypass and a preparation method thereof. Background technique [0002] Bypass surgery, as the name suggests, is to take the patient's own blood vessels (such as the internal thoracic artery, the great saphenous vein of the lower limbs, etc.) or blood vessel substitutes, and connect the distal end of the narrowed coronary artery to the aorta, allowing blood to pass through the narrowed part. Reach the ischemic site, improve myocardial blood supply, and then achieve the purpose of relieving angina symptoms, improving heart function, improving the quality of life of patients and prolonging life. This operation is called coronary artery bypass grafting, which establishes a smooth path between the aortic root full of arterial blood and the ischemic myocardium. Therefore, some people vividly ca...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more